Article From: "Casey Coombs"   Read full article

Former Juno Therapeutics Inc. executives Hans Bishop and Steve Harr have co-founded a new biotech, Sana Biotechnology Inc., less than a year after leading Juno through a $9 billion acquisition by Celgene Corp.